[OFER-TRABEC] NAC: Postdoctoral Position in Breast Cancer Personalize

***********************************************************************
(c)OFER-TRABEC es un servicio ofrecido por el Centro de Comunicaciones RedIRIS
(Permitida la reproducción siempre que se cite la fuente de este Servicio).
***********************************************************************
***********************************************************************
Se agradece la colaboración en OFER-TRABEC del:
Centro de Información Administrativa de Presidencia del Gobierno
------------------------

---Procedencia:
Institución:IDIBELL
Contacto correo-e:miguelangel.pujana@gmail.com
---
Major advances in the understanding of the genetic basis of breast cancer have been made in recent years, but these advances have not led to significant improvements in clinical practice. Moreover, knowledge of the tumor/somatic alterations involved in the disease is disperse, impeding transfer to the clinic and the development of personalized treatments. In this scenario, our group aims at integrating basic and translational research to better define breast cancer subtypes and develop personalized medicine principles.

The Breast Cancer and Systems Biology Group in the Catalan Institute of Oncology (IDIBELL, Barcelona) is interested in finding a highly motivated postdoctoral candidate to apply for a research contract funded by Spanish Association Against Cancer (AECC). The AECC call offers three possibilities, please visit www.aecc.es.

Requirements:
1) PhD degree;
2) postdoctoral experience (at least 4 years for B category)
3) strong publication record in cancer biology

Candidates should send a CV, motivation letter, and 3 contact references no latter than December 31st to Dr. Miquel Àngel Pujana (miguelangel.pujana@gmail.com)


----------------
Información complementaria de la oferta:
Recent publications by the group:
Maxwell et al. (2011). Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer. PLoS Biology Nov;9(11):e1001199.
Martrat et al. (2011). Exploring the link between MORF4L1 and risk of breast cancer. Breast Cancer Research 13(2):R40.
Aguilar et al. (2010). Biological reprogramming in acquired resistance to endocrine treatment of breast cancer. Oncogene 29(45):6071-83.

*************************************************************************
Para darse de baja OFER-TRABEC pinche y envíe:
mailto:OFER-TRABEC-signoff-request@listserv.rediris.es
*************************************************************************